The Indian Pharmacopoeia Commission (IPC) has entered into a formal agreement with the Uttar Pradesh Promote Pharma Council (UPPPC), marking a fresh push to strengthen pharmaceutical quality standards and regulatory practices across the state. The agreement was formalized on 14 July 2026 at the India Expo Mart in Greater Noida, on the sidelines of the YEIDA MedTech Investors Meet and Site Visit.
Under this collaboration, both bodies plan to jointly tackle regulatory compliance, raise awareness around pharmacovigilance and materiovigilance, and roll out training sessions and workshops for industry stakeholders. The partnership also emphasizes academic and research linkages, along with dedicated support for small and medium pharma enterprises through digital platforms designed for reporting adverse events.
Patient safety remains a central focus, with plans for enhanced quality checks and post-market monitoring of medical products. Officials describe the tie-up as part of IPC’s broader mission to elevate healthcare standards nationally while helping position Uttar Pradesh as a major center for pharmaceutical and medical device manufacturing. The initiative is expected to foster a more transparent, innovation-driven, and globally competitive healthcare ecosystem in the region.
Written By: Sayan Das
Graphics by: Pramit Hazra
